Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/20079640

Download in:

View as

General Info

PMID
20079640